Genentech
2024 Summer Intern - Business Development
This job is now closed
Job Description
- Req#: 202309-120865
A Business Development Summer Associate may work with multiple stakeholders and departments in the company, such as Research, Finance, Legal, Marketing, Product Development, Regulatory, and Process Development, to source and evaluate new therapeutic opportunities and to assess the technical merit, competitive outlook and strategic fit of licensing opportunities relative to Genentech’s existing portfolio.
Business Development Summer Associate project work has included scientific and business landscaping and partnering strategy formation in areas of high priority (e.g. regenerative medicine, cell therapy, diagnostics, neuroimmunology, cutting edge delivery technologies and other key scientific areas) and supporting ongoing deal discussions.
Intensive 12-weeks, full time (40 hours per week) paid internship.
Program start dates are in May and June 2024.
Ownership of challenging and impactful business-critical projects.
Work with some of the most talented people in the biotechnology industry.
Final presentations of project work to senior leaders.
Lead or participate in intern committees to design and coordinate program events and initiatives.
Professional & personal development curriculum throughout the program, including networking opportunities, workshops, and panel discussions.
Participate in volunteer projects, social events, and team-building activities.
3-4 years of experience in life sciences, finance, consulting, drug development or equivalent
Graduate Level Only: Pursuing Masters or PhD, or graduated from Masters or PhD within the last 2 years.
Strong quantitative and analytical skills
Strong scientific acumen and interest
Demonstrated ability and experience in effectively interacting with executives and senior leaders
Demonstrated leadership skills and experience
Excellent oral and written communication skills
2024 Summer Intern - Business Development
Department Summary
Business Development MBA Internships – An Opportunity for Growth
The Genentech MBA Internship Program is an intensive 12 week opportunity that provides work within a fast-paced and challenging environment. MBA interns contribute to meaningful projects, interacting and working side-by-side with biotech industry experts. Our internship program also provides a robust speaker series, which allows interns to hear from top executives throughout the summer. Genentech relies heavily on our internship talent pool to fill full-time positions, including rotational opportunities within the organization.
Roche’s Pharma Partnering department is a global, diverse group of professionals that apply scientific, financial and negotiating expertise to establish collaborations that facilitate development and commercialization of therapies to bring important new medicines to patients. Roche's Business Development group continually strives to identify and evaluate novel opportunities that result in strategic alliances with partners.
This internship position is located in South San Francisco , on site.
Key Responsibilities
Program Highlights
Who You Are
Qualifications for BD Summer Associate Internship positions include but are not limited to:
Along with the submission of your CV, a cover letter is optional.
Relocation benefits are not available for this job posting.
The expected salary range for this position based on the primary location for this position of California is $21.00 - $50.00 per hour. Actual pay will be determined based on experience, qualifications, geographic location, and other job-related factors permitted by law. This position also qualifies for paid holiday time off benefits.
#SummerAssociates2024
Genentech is an equal opportunity employer, and we embrace the increasingly diverse world around us. Genentech prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity or expression, national origin or ancestry, age, disability, marital status and veteran status.
About the company
Genentech, Inc., is an American biotechnology corporation which became a subsidiary of Roche in 2009.